Lv5
890 积分 2021-06-03 加入
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
3个月前
已完结
Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia
4个月前
已完结
PDE4 inhibitors in psoriasis therapy: current insights and future directions
4个月前
已完结
Treatment of chronic plaque psoriasis: An overview on current update
4个月前
已关闭
Final analysis of camrelizumab plus chemotherapy for untreated advanced or metastatic esophageal squamous cell carcinoma: The ESCORT-1st trial
5个月前
已完结
Inflammation-directed nanozyme-eluting hydrogel coating promotes vascular tissue repair by restoring reactive oxygen species homeostasis
5个月前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
6个月前
已完结
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
10个月前
已关闭
Antibody-Drug Conjugates in Gynecologic Cancers
10个月前
已完结
HER2-targeted therapies beyond breast cancer — an update
10个月前
已完结
皖公网安备34019202002308
